Drug Type CAR-M |
Synonyms- |
Target |
Action inhibitors |
Mechanism CSPG4 inhibitors(chondroitin sulfate proteoglycan 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | United States | 30 Aug 2021 |